SG Americas Securities
NMTR

SG Americas Securities’s 9 Meters Biopharma NMTR Stock Holding History

SG Americas Securities’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,509
Closed -$8K – 3672
2022
Q2 		$8K Buy
+1,509
New +$14.2K ﹤0.01% 3376
2022
Q1 		– Sell
-2,880
Closed -$56K – 3597
2021
Q4 		$56K Sell
2,880
-2,519
-47% -$56.3K ﹤0.01% 3179
2021
Q3 		$140K Buy
5,399
+4,022
+292% +$94.8K ﹤0.01% 3475
2021
Q2 		$30K Buy
+1,377
New +$33.8K ﹤0.01% 2765
2019
Q2 		– Sell
-728
Closed -$28K – 3529
2019
Q1 		$28K Buy
+728
New +$31.5K ﹤0.01% 3254

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

SG Americas Securities's NMTR Position: Q3 2022 in Review

SG Americas Securities sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 1,509 shares — an estimated $8K sold.

SG Americas Securities first reported a position in NMTR in Q1 2019 and held it in 5 quarters. The position peaked at $140K in Q3 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • SG Americas Securities reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 1,509 9 Meters Biopharma shares in Q3 2022, an estimated $8K.
  • SG Americas Securities first reported a position in 9 Meters Biopharma in Q1 2019 and held it in 5 quarters.
  • SG Americas Securities's 9 Meters Biopharma position peaked at $140K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.